Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × cabozantinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 66 Carcinoma, Hepatocellular 23 Prostatic Neoplasms 20 Neoplasm Metastasis 17 Neoplasms 15 Kidney Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Neuroendocrine Tumors 8 Carcinoma, Medullary 8 Melanoma 7 Carcinoma, Transitional Cell 7 Brain Neoplasms 7 Urinary Bladder Neoplasms 6 Sarcoma 6 Osteosarcoma 6 Colorectal Neoplasms 6 Breast Neoplasms 6 Thyroid Neoplasms 5 Sarcoma, Ewing 5 Recurrence 5 Pancreatic Neoplasms 5 Clear-cell metastatic renal cell carcinoma 5 Carcinoma 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Liver Neoplasms 3

Interventions

AZD 6244 17 trametinib 5 Lovastatin 5 Deoxycholic Acid 4 Lasers, Solid-State 3 pirfenidone 2 mirdametinib 2 fludarabine 2 binimetinib 2 Vincristine 2 Vinblastine 2 Specimen Handling 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Everolimus 2 Carboplatin 2 Blood Specimen Collection 2 Biopsy 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 talimogene laherparepvec 1 pomalidomide 1 peginterferon alfa-2b 1 omipalisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06502171 2026-03-12

NF113

University of Alabama at Birmingham

Phase 1 Not yet recruiting

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡